Parkwood »

Monte Rosa Therapeutics shares owned by Parkwood

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Parkwood from 13F filings

Historical chart of Parkwood investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Parkwood consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Parkwood

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.2M 323k 6.94
2024-09-30 $2.3M 427k 5.30

More positions owned by Parkwood

Vanguard Total Stock Mkt Etf Exchange Traded Funds (VTI)
Spdr S&p Biotech Etf Equity Options Call Option (XBI)
iShares 20 Year Treasury Bond ETF Equity Options Call Option (TLT)
Novo-nordisk A/s-spons American Depository Receipt (NVO)
Alphabet Inc-cl C Common Stocks (GOOG)
Vanguard Tot World Stk Etf Exchange Traded Funds (VT)
Elevance Health Ord Equity (ELV)
Ishares Bitcoin Trust Etf Exchange Traded Funds (IBIT)
Philip Morris International Common Stocks (PM)
Cdn Natural Resource Ord Equity (CNQ)
Servicenow Common Stocks (NOW)
Meta Platforms Inc-class A Common Stocks (META)
Td Synnex Ord Equity (SNX)
Uber Technologies Common Stocks (UBER)
Us Bancorp Common Stocks (USB)

View all positions for Parkwood

Top funds holding Monte Rosa Therapeutics

NEA Management Company
T. Rowe Price Associates
Versant Venture Management
FMR
Baker Bros. Advisors
venBio Select Advisor
BlackRock
Vanguard Group
BVF
Morgan Stanley
Suvretta Capital Management
Aisling Capital Management
Alphabet
State Street Corporation
Geode Capital Management

View all funds holding Monte Rosa Therapeutics